Québec Aerospace 2017
As cost pressures propagate from OEM’s down the value chain, does Industry 4.0 hold the solutions?
United States Biopharmaceuticals 2017
The cost of developing new drugs and cures is enormous. A delicate balance between encouraging innovation and controlling the cost of medicines has to be maintained.